Cargando…
The first experience with sodium‐glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure
In congenitally corrected transposition of the great arteries, the morphological right ventricle supports the systemic circulation. This chronic exposure to pressure overload ultimately leads to systemic right ventricular (sRV) dysfunction and heart failure. Pharmacological options for the treatment...
Autores principales: | Egorova, Anastasia D., Nederend, Marieke, Tops, Laurens F., Vliegen, Hubert W., Jongbloed, Monique R.M., Kiès, Philippine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065858/ https://www.ncbi.nlm.nih.gov/pubmed/35355435 http://dx.doi.org/10.1002/ehf2.13871 |
Ejemplares similares
-
The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease
por: Neijenhuis, Ralph M. L., et al.
Publicado: (2023) -
Sacubitril/valsartan in the treatment of systemic right ventricular failure
por: Zandstra, Tjitske E, et al.
Publicado: (2021) -
Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
por: Nederend, Marieke, et al.
Publicado: (2021) -
Atrioventricular Block Necessitating Chronic Ventricular Pacing After Tricuspid Valve Surgery in Patients With a Systemic Right Ventricle: Long-Term Follow-Up
por: Nederend, Marieke, et al.
Publicado: (2022) -
Validation and Feasibility of Echocardiographic Assessment of Systemic Right Ventricular Function: Serial Correlation With MRI
por: Zandstra, Tjitske E., et al.
Publicado: (2021)